These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium. O'Connor AB Ann Intern Med; 2006 Jan; 144(2):148; author reply 148-9. PubMed ID: 16418423 [No Abstract] [Full Text] [Related]
5. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium. Good CB; Longo L Ann Intern Med; 2006 Jan; 144(2):147; author reply 148-9. PubMed ID: 16418422 [No Abstract] [Full Text] [Related]
6. [The first long-acting anticholinergic drug. COPD drug with 24-hour effect]. MMW Fortschr Med; 2002 Jun; 144(26):52. PubMed ID: 12154479 [No Abstract] [Full Text] [Related]
7. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)]. Osztovits J; Fehér J Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002 [No Abstract] [Full Text] [Related]
8. Summaries for patients. Tiotropium and the treatment of chronic obstructive lung disease. Ann Intern Med; 2005 Sep; 143(5):I20. PubMed ID: 16144886 [No Abstract] [Full Text] [Related]
9. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety? McIvor RA Pol Arch Med Wewn; 2009 Nov; 119(11):697-8. PubMed ID: 19920792 [No Abstract] [Full Text] [Related]
10. [After diagnosis 11 more years remain. COPD alarm in Europe!]. Wepner U MMW Fortschr Med; 2002 Oct; 144(44):12-3. PubMed ID: 12494590 [No Abstract] [Full Text] [Related]
11. More than just reassurance on tiotropium safety. Jenkins CR N Engl J Med; 2013 Oct; 369(16):1555-6. PubMed ID: 24131181 [No Abstract] [Full Text] [Related]
13. [Not Available]. Fischer S Med Monatsschr Pharm; 2014 Feb; 37(2):79-80. PubMed ID: 24624613 [No Abstract] [Full Text] [Related]
14. Response. Nishimura N J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):121. PubMed ID: 23550603 [No Abstract] [Full Text] [Related]
15. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease]. Ma J; Zhou Z; Tang Y; Zhong N Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564 [TBL] [Abstract][Full Text] [Related]
16. Tiotropium and the risk of death in COPD. Wise RA N Engl J Med; 2014 Jan; 370(5):482. PubMed ID: 24476441 [No Abstract] [Full Text] [Related]
17. Tiotropium and the risk of death in COPD. Loke YK; Singh S; Furberg CD N Engl J Med; 2014 Jan; 370(5):480-1. PubMed ID: 24476442 [No Abstract] [Full Text] [Related]
18. Tiotropium and the risk of death in COPD. Verhamme KM; van Blijderveen N; Sturkenboom MC N Engl J Med; 2014 Jan; 370(5):481-2. PubMed ID: 24476443 [No Abstract] [Full Text] [Related]
19. Tiotropium and the risk of death in COPD. Jenkins CR N Engl J Med; 2014 Jan; 370(5):482-3. PubMed ID: 24482820 [No Abstract] [Full Text] [Related]
20. Tiotropium effective in treatment of COPD. Kripke C Am Fam Physician; 2005 Dec; 72(11):2219-20. PubMed ID: 16345146 [No Abstract] [Full Text] [Related] [Next] [New Search]